Journal Browser

Go Edit a Special Issue


Special Issue Title:

COVID-19 in the Emergency Department: Epidemiology and changes throughout the pandemic

Deadline for manuscript submissions: 08 February 2022

Print Special Issue Flyer (17)

Special Issue Editor

  • Guest Editor

    Dr. Antonio J. Láinez Ramos-BossiniE-MailWebsite

    Emergency radiologist, Department of Radiology, Virgen de las Nieves University Hospital, Granada. Spain; Collaborating professor, department of Radiology and Physical Medicine, University of Granada, Spain; Co-leading researcher of the ‘Artificial Intelligence Applied to the Diagnosis and Prognosis of COVID-19’ project at the Distributed Computational Intelligence and Time Series Lab, University of Granada, Spain.

    Interests: Emergency radiology, Artificial intelligence, COVID-19, Epidemiology, Medical education

Special Issue Information

The unprecedented impact of the COVID-19 pandemic has prompted a massive production of clinical research. However, many questions remain unanswered. In this regard, there are several limitations that hinder patient management in the emergency department, a cornerstone of hospital care for COVID-19 patients. Common problems in clinical practice include logistics and triaging of patients with non-specific symptoms, early identification of high-risk patients who should require hospital admission and more aggressive therapeutic approaches, or detection of associated complications such as pulmonary embolism. Changes in virus dynamics over time limit our understanding and ability to predict these clinical concerns in real-world practice. In this context, advanced statistics and artificial intelligence models have shown promising potential to assist specialists involved in patient management in the emergency department. However, there is significant variability and limitations depending on the methodologies, purposes and populations from which data are obtained.

This special issue focuses on exploiting epidemiological data of patients admitted to the emergency department due to suspected or confirmed COVID-19 infection with the aim to further our understanding of the dynamics of the virus and aid patient management in the emergency department. Notable interest topics include but are not limited to disease prevalence, diagnosis, laboratory and radiological findings, clinical management, complications and mortality. Conventional statistics and artificial intelligence methods analyzing differences between patients with overlapping symptoms, predicting patient outcomes, or assisting emergency specialists in decision-making regarding particular clinical questions which arise in daily practice are especially encouraged. In addition, studies tracking changes at different stages of the pandemic are of particular interest to gain insight into the clinical variability of COVID-19.

We welcome original articles, reviews and commentaries focused on the subject. The goal is to gain a longitudinal perspective on the challenges of the pandemics in the emergency department: how it started, the status quo and what can we expect with increasing vaccination across different countries.


SARS-CoV-2, COVID-19, Emergency care, Longitudinal management, Prognosis, Artificial intelligence, Statistics, Epidemiology

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Published Papers (5 papers)

Open Access Special Issue

Factors associated with readmission to the Emergency Department in a cohort of COVID-19 hospitalized patients

Álvaro Romero-Duarte,Mario Rivera-Izquierdo,Antonio Jesús Láinez-Ramos-Bossini,Pablo Redruello-Guerrero,Antonio Cárdenas-Cruz

Online publish date: 16 June 2021

DOI: 10.22514/sv.2021.106

Abstract ( 511 ) PDF (643.83 kB) ( 154 )

Open Access Special Issue

Machine learning techniques as an efficient alternative diagnostic tool for COVID-19 cases

Nicolás Bustos,Manuel Tello,Guillermo Droppelmann,Nicolás García,Felipe Feijoo,Víctor Leiva

Online publish date: 24 June 2021

DOI: 10.22514/sv.2021.110

Abstract ( 1494 ) PDF (6.72 MB) ( 298 )

Open Access Special Issue

A statistical analysis for the epidemiological surveillance of COVID-19 in Chile

Nixon Jerez-Lillo,Bernardo Lagos Álvarez,Joel Muñoz Gutiérrez,Jorge I. Figueroa-Zúñiga,Víctor Leiva

Online publish date: 27 July 2021

DOI: 10.22514/sv.2021.130

Abstract ( 765 ) PDF (1 MB) ( 223 )

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time